December 29, 2022 — The Smidt Heart Institute at Cedars-Sinai was named a Mitral Valve Repair Reference Center, a ...
December 28 2022 — Abiomed announces the United States Food and Drug Administration (FDA) has approved the version of ...
December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients ...
December 26, 2022 — Cardiologists, team physicians, certified athletic trainers, advanced practice providers, fellows ...
December 26, 2022 — AliveCor, the global leader in FDA-cleared personal electrocardiogram (ECG) technology, today ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...
December 23, 2022 — According to Coherent Market Insights, the global Drug Eluting Stents market is estimated to be ...
December 23, 2022 — Electroducer, a company developing an innovative and cost-effective medical device for the treatment ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
December 22, 2022 — Johnson & Johnson today announced it has completed its acquisition of Abiomed, Inc. Abiomed is now ...
December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...
December 22, 2022 — Acutus Medical, Inc., an arrhythmia management company focused on improving the way cardiac ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
December 22, 2022 — New research findings have revealed an underlying genetic cause for why some children who have had ...
December 21, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting ...
December 21, 2022 — The Smidt Heart Institute at Cedars-Sinai is again expanding its geographic reach and surgical ...
December 29, 2022
